日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 1 open-label study of ASP9801, an oncolytic virus, in patients with advanced or metastatic solid tumors

一项针对晚期或转移性实体瘤患者的溶瘤病毒ASP9801的1期开放标签研究

Villano, John L; Luke, Jason J; Julian, Ricklie; Fountzilas, Christos; Patel, Manish R; Chisamore, Michael J; Bhattacharya, Pranob; Takeshita, Shigeru; Soukharev, Serguei; Yamada, Shunsuke; Zhang, Leshi; Wentzel, Kristopher P

Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

PORTER研究的临床和转化结果:一项针对转移性去势抵抗性前列腺癌的联合免疫疗法多队列I期平台试验

Galsky, Matthew D; Autio, Karen A; Cabanski, Christopher R; Wentzel, Kristopher; Graff, Julie N; Friedlander, Terence W; Howes, Timothy R; Shotts, Kristin M; Densmore, Julie; Spasic, Marko; Da Silva, Diane M; Chen, Richard O; Lata, Jennifer; Skolnik, Jeffrey; Keler, Tibor; Yellin, Michael J; LaVallee, Theresa M; Fairchild, Justin; Boffo, Silvia; O'Donnell-Tormey, Jill; Dugan, Ute; Bhardwaj, Nina; Subudhi, Sumit K; Fong, Lawrence

Safety and Efficacy of Copanlisib in Combination with Nivolumab: A Phase Ib Study in Patients with Advanced Solid Tumors.

Copanlisib 与 Nivolumab 联合治疗晚期实体瘤患者的安全性和有效性:一项 Ib 期研究

Carneiro Benedito A, Jotte Robert M, Gabrail Nashat Y, Wentzel Kristopher, Huang Funan, Chaturvedi Shalini, Weispfenning Anke, Hiemeyer Florian, Morcos Peter N, Mongay Soler Lidia, Childs Barrett H, Hansen Aaron R

Endocrine Autoantibodies Determine Immune Checkpoint Inhibitor-induced Endocrinopathy: A Prospective Study

内分泌自身抗体决定免疫检查点抑制剂诱导的内分泌疾病:一项前瞻性研究

Labadzhyan, Artak; Wentzel, Kristopher; Hamid, Omid; Chow, Kamlynn; Kim, Sungjin; Piro, Lawrence; Melmed, Shlomo